About us
About the Access Campaign

Our 2022 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Active campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives

Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

About us
About the Access Campaign

Our 2022 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Active campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives

Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

Newsletter

The Access Campaign Newsletters

Read, watch, share

Trips WAIVER protest at MC12 event in Geneva, Switzerland

Newsletter |

24 July 2022

COVID-19

WTO adopts inadequate text, not a real Waiver on COVID monopolies

Newsletter |

05 May 2022

COVID-19

Reject the FLAWED COVID proposal at WTO for equitable access to medical tools

Newsletter cover image

Newsletter |

28 April 2022

COVID-19

Share vaccine tech! Prepare for the future!

Wishlist 2022 - Cover image

Newsletter |

01 January 2022

Diabetes HIV/AIDS Tropical & neglected diseases Vaccines

Our Wishlist for 2022

Share mRNA tech - Solidarity, global public good, sharing is caring

Newsletter |

03 November 2021

COVID-19

No profit in a pandemic! Moderna must share COVID-19 vaccine technology now

South Africa TRIPS waiver protest in front of US embassy

Newsletter |

11 October 2021

COVID-19

Break the TRIPS Waiver deadlock!

870 million estimated doses a handful of high-income countries will have hoarded in 2021

Newsletter |

07 October 2021

COVID-19

Redistribute excess COVID-19 vaccines to people who need them most

Newsletter |

02 October 2021

COVID-19

The Waiver campaign is one year old. It’s not a time to celebrate but a time to act.